
Vaccines Market Analysis and Forecast to 2031: By Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococca
Description
Vaccines Market Analysis and Forecast to 2031: By Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, & Rubella, Diphtheria, Pertussis, & Tetanus {DPT}, Polio, Hepatitis, Other Indications), and Region
Vaccines can be created by using a whole organism, such as a bacterium or virus, or by using parts of the organism, such as proteins or toxins.
The first step in creating a vaccine is to identify the disease-causing organism. Once the organism is identified, scientists can then determine which parts of the organism are responsible for causing the disease. These parts are then isolated and used to create a vaccine.
Vaccines can be created using different methods, including genetic engineering, cell culture, or whole-organism fermentation. Genetic engineering is the process of altering the DNA of an organism to create a new strain that is resistant to a particular disease. Cell culture is the process of growing cells in a laboratory. Whole-organism fermentation is the process of growing the organism in a controlled environment, such as in a laboratory.
Key Trends and Drivers
The rise in incidence of infectious diseases and the growing awareness of the importance of vaccination are the major factors driving the growth of the vaccines market. The increasing government initiatives to promote vaccination, the availability of funding for research and development, and the launch of new vaccines are also contributing to the market growth. However, the high cost of vaccines and the stringent regulatory requirements are restraining the market growth.
Restraints & Challenges
Lack of awareness about vaccination and its benefits is a key restraint in the growth of the vaccines market. Vaccination is one of the most effective ways to prevent the spread of infectious diseases, yet many people are still unaware of its importance. In some parts of the world, vaccination rates are low due to cultural beliefs or lack of access to healthcare. This can lead to outbreaks of preventable diseases, which can be deadly.
Stringent regulations are another challenge faced by the vaccines market. The development and manufacturing of vaccines is a complex process that is regulated by various government agencies. These regulations can vary from country to country, making it difficult to develop and market new vaccines globally.
Market SegmentsBy Technology Type
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Vaccines can be created by using a whole organism, such as a bacterium or virus, or by using parts of the organism, such as proteins or toxins.
The first step in creating a vaccine is to identify the disease-causing organism. Once the organism is identified, scientists can then determine which parts of the organism are responsible for causing the disease. These parts are then isolated and used to create a vaccine.
Vaccines can be created using different methods, including genetic engineering, cell culture, or whole-organism fermentation. Genetic engineering is the process of altering the DNA of an organism to create a new strain that is resistant to a particular disease. Cell culture is the process of growing cells in a laboratory. Whole-organism fermentation is the process of growing the organism in a controlled environment, such as in a laboratory.
Key Trends and Drivers
The rise in incidence of infectious diseases and the growing awareness of the importance of vaccination are the major factors driving the growth of the vaccines market. The increasing government initiatives to promote vaccination, the availability of funding for research and development, and the launch of new vaccines are also contributing to the market growth. However, the high cost of vaccines and the stringent regulatory requirements are restraining the market growth.
Restraints & Challenges
Lack of awareness about vaccination and its benefits is a key restraint in the growth of the vaccines market. Vaccination is one of the most effective ways to prevent the spread of infectious diseases, yet many people are still unaware of its importance. In some parts of the world, vaccination rates are low due to cultural beliefs or lack of access to healthcare. This can lead to outbreaks of preventable diseases, which can be deadly.
Stringent regulations are another challenge faced by the vaccines market. The development and manufacturing of vaccines is a complex process that is regulated by various government agencies. These regulations can vary from country to country, making it difficult to develop and market new vaccines globally.
Market SegmentsBy Technology Type
- Recombinant & Conjugate Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Others
- Pneumococcal Disease
- Influenza
- Human Papilloma Virus
- Meningococcal Disease
- Rotavirus
- Varicella, Measles, Mumps, & Rubella
- Diphtheria, Pertussis, & Tetanus {DPT}
- Polio
- Hepatitis
- Other Indications
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
139 Pages
- 1.Global Vaccines Market Overview
- 1.1 Objectives of the Report
- 1.2 Market Definition and Scope of the Report
- 1.3 Research Methodologies
- 1.4 Market Estimation Technique
- Executive Summary
- 2.1 Summary
- 2.2 Key Highlights of the Market
- Global Vaccines Market Outlook
- 3.1 Market Segmentation
- 3.2 Market Dynamics
- 3.3 Porters Five Forces Analysis
- 3.4 PESTLE Analysis
- 3.5 Value Chain Analysis
- 3.6 Impact of Russia and Ukraine War
- Economic Impact of COVID-19
- 4.1 Overall Impact of COVID
- 4.2 Impact of COVID on Global Vaccines Market
- 4.3 Impact of COVID-19 on the Economies
- 4.3.1 India
- 4.3.2 China
- 4.3.3 US
- 4..4 Canada
- Global Vaccines Market by Age Group
- 5.1 Overview
- 5.2 Market Size and Forecast
- 5.3 Pediatric
- 5.3.1 Market Size and forecast
- 5.4 Adult
- 5.4.1 Market Size and Forecast
- Global Vaccines Market by Disease
- 6.1 Overview
- 6.1.1 Market Share and Forecast
- 6.2 Cancer
- 6.2.1 Market Share and Forecast
- 6.3 Hepatitis
- 6.3.1 Market Size and Forecast
- 6.4 Pneumococcal Diseases
- 6.4.1 Market Size and Forecast
- 6.5 DTP
- 6.5.1 Market Size and Forecast
- 6.6 Influenza
- 6.6.1 Market Size and Forecast
- 6.7 Human Papilloma Virus
- 6.7.1 Market Size and Forecast
- 6.8 Meningococcal Disease
- 6.8.1 Market Size and Forecast
- 6.9 Polio
- 6.9.1 Market Size and Forecast
- 6.10 Rotavirus
- 6.10.1 Market Size and Forecast
- 6.11 COVID-19
- 6.11.1 Market Size and Forecast
- 6.12 Others
- 6.12.1 Market Size and Forecast
- Global Vaccines Market by Technology
- 7.1 Overview
- 7.1.1 Market Size and Forecast
- 7.2 Conjugated
- 7.2.1 Market Size and Forecast
- 7.3 Live
- 7.3.1 Market Size and Forecast
- 7.4 Inactivated
- 7.4.1 Market Size and Forecast
- 7.5 Recombinant
- 7.5.1 Market Size and Forecast
- 7.6 Toxoid
- 7.6.1 Market Size and Forecast
- 7.7 Others
- 7.7.1 Market Size and Forecast
- Global Vaccines Market by Geography
- 8.1 Global Vaccines Revenue and Share by Geography
- 8.1.1 Global Vaccines Market Size by Region
- 8.2 North America
- 8.2.1 Overview
- 8.2.2 Market Size and Forecast, by Age Group
- 8.2.3 Market Size and Forecast, by Disease
- 8.2.4 Market Size and Forecast, by Technology
- 8.2.5 Market Size and Forecast, by Country
- 8.2.6 The U.S.
- 8.2.6.1 Market Size and Forecast, by Age Group
- 8.2.6.2 Market Size and Forecast, by Disease
- 8.2.6.3 Market Size and Forecast, by Technology
- 8.2.7 Canada
- 8.2.7.1 Market Size and Forecast, by Age Group
- 8.2.7.2 Market Size and Forecast, by Disease
- 8.2.7.3 Market Size and Forecast, by Technology
- 8.2.8 Mexico
- 8.2.8.1 Market Size and Forecast, by Age Group
- 8.2.8.2 Market Size and Forecast, by Disease
- 8.2.8.3 Market Size and Forecast, by Technology
- 8.3 Europe
- 8.3.1 Overview
- 8.3.2 Market Share and Forecast, by Age Group
- 8.3.3 Market Size and Forecast, by Disease
- 8.3.4 Market Size and Forecast, by Technology
- 8.3.5 Market Size and Forecast, by Country
- 8.3.6 The U.K.
- 8.3.6.1 Market Size and Forecast, by Age Group
- 8.3.6.2 Market Size and Forecast, by Disease
- 8.3.6.3 Market Size and Forecast, by Technology
- 8.3.7 Germany
- 8.3.7.1 Market Size and Forecast, by Age Group
- 8.3.7.2 Market Size and Forecast, by Disease
- 8.3.7.3 Market Size and Forecast, by Technology
- 8.3.8 Italy
- 8.3.8.1 Market Size and Forecast, by Age Group
- 8.3.8.2 Market Size and Forecast, by Disease 8.3.8.3 Market Size and Forecast, by Technology
- 8.3.9 France
- 8.3.9.1 Market Size and Forecast, by Age Group
- 8.3.9.2 Market Size and Forecast, by Disease
- 8.3.9.3 Market Size and Forecast, by Technology
- 8.3.10 Rest of Europe
- 8.3.10.1 Market Size and Forecast, by Age Group
- 8.3.10.2 Market Size and Forecast, by Disease
- 8.3.10.3 Market Size and Forecast, by Technology
- 8.4 Asia Pacific
- 8.4.1 Overview
- 8.4.2 Market Size and Forecast, by Age Group
- 8.4.3 Market Size and Forecast, by Disease
- 8.4.4 Market Size and Forecast, by Technology
- 8.4.5 Market Size and Forecast, by Country
- 8.4.6 China
- 8.4.6.1 Market Size and Forecast, by Age Group
- 8.4.6.2 Market Size and Forecast, by Disease
- 8.4.6.3 Market Size and Forecast, by Technology
- 8.4.7 India
- 8.4.7.1 Market Size and Forecast, by Age Group
- 8.4.7.2 Market Size and Forecast, by Disease
- 8.4.7.3 Market Size and Forecast, by Technology
- 8.4.8 South Korea
- 8.4.8.1 Market Size and Forecast, by Age Group
- 8.4.8.2 Market Size and Forecast, by Disease
- 8.4.8.3 Market Size and Forecast, by Technology
- 8.4.10 Rest of APAC
- 8.4.10.1 Market Size and Forecast, by Age Group
- 8.4.10.2 Market Size and Forecast, by Disease
- 8.4.10.3 Market Size and Forecast, by Technology
- 8.5 Rest of the World
- 8.5.1 Overview
- 8.5.2 Market Size and Forecast, by Age Group
- 8.5.3 Market Size and Forecast, by Disease
- 8.5.4 Market Size and Forecast, by Technology
- 8.5.5 Market Size and Forecast, by Country
- 8.5.6 Latin America
- 8.5.6.1 Market Size and Forecast, by Age Group
- 8.5.6.2 Market Size and Forecast, by Disease
- 8.5.6.3 Market Size and Forecast, by Technology
- 8.5.7 Middle East
- 8.5.7.1 Market Size and Forecast, by Age Group
- 8.5.7.2 Market Size and Forecast, by Disease
- 8.5.7.3 Market Size and Forecast, by Technology
- 8.5.8 Africa
- 8.5.8.1 Market Size and Forecast, by Age Group
- 8.5.8.2 Market Size and Forecast, by Disease
- 8.5.8.3 Market Size and Forecast, by Technology
- Competitive Landscape
- 9.1 Overview
- 9.2 Market Share Analysis
- 9.3 Ranking by Vaccines Revenue
- Company Profiles
- 10.1 GlaxoSmithKline
- 10.1.1 Company Snapshot
- 10.1.2 Business Performance
- 10.1.3 Age Group Offering
- 10.1.4 Key Developmental Strategies
- 10.1.5 SWOT Analysis
- 10.2 Abbott
- 10.3 Astellas Pharma, Inc.
- 10.4 AstraZeneca
- 10.5 Serum Institute of India
- 10.6 CSL Limited
- 10.7 Emergent BioSolutions, Inc.
- 10.8 Merck & Co. Inc.
- 10.9 Novavax
- 10.10 Pfizer
- 10.11 Sanofi
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.